Follow Us GraphicFacebook IconTwitter IconLinkedIn Icon
Search Graphic

Expert Financial Analysis and Reporting

Repligen: Very Strong Growth in Sales and Earnings Continues (RGEN, 29.37, Buy)

Investment Thesis

Repligenís operating business results continue to be very strong as second quarter bioprocessing sales increased 36%. For perspective, full…
Read more…